Entresto 24 MG-26 MG tablet 180S
Ended Awarded Last action
- Contract number
- SPE2DR26FC7DX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,670
Award facts
- Contract value 100% obligated
- $15,670.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count units) with a contract ceiling value of $15,670.14. This is a firm fixed-price delivery order with no set-aside designation, issued competitively. The order is scheduled for ultimate completion by December 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of competitively awarded federal contracts covering a wide range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. The DLA Troop Support Medical IDC enables AmerisourceBergen to supply pharmaceutical products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the agency planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple regional awards.
Quick answers
Who was awarded contract SPE2DR26FC7DX?
SPE2DR26FC7DX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FC7DX worth?
The government has obligated $15,670 on SPE2DR26FC7DX.
Is contract SPE2DR26FC7DX an order under another contract?
Yes. SPE2DR26FC7DX is a delivery order under SPE2DR25D2217, an indefinite delivery contract.
Was contract SPE2DR26FC7DX competed?
The extent of competition for SPE2DR26FC7DX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award